trinitrobenzenesulfonic acid has been researched along with Pancreatic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, W; Guo, C; He, S; Hu, G; Ni, J; Shen, J; Wan, R; Wang, F; Wang, X; Xiong, J; Xu, L; Yang, L | 1 |
| Cai, JT; Du, Q; Gao, ZQ; Qian, KD; Wang, CH; Xie, CG; Ye, B | 1 |
2 other study(ies) available for trinitrobenzenesulfonic acid and Pancreatic Diseases
| Article | Year |
|---|---|
L-cysteine administration attenuates pancreatic fibrosis induced by TNBS in rats by inhibiting the activation of pancreatic stellate cell.
Topics: Animals; Cysteine; Fibrosis; Pancreatic Diseases; Pancreatic Stellate Cells; Pancreatitis, Chronic; Rats; Treatment Outcome; Trinitrobenzenesulfonic Acid | 2012 |
[Effect of emodin on pancreatic fibrosis: experiment with rats].
Topics: Animals; Blotting, Western; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Emodin; Fibrosis; Hyaluronic Acid; Laminin; Male; Pancreas; Pancreatic Diseases; Phytotherapy; Radioimmunoassay; Random Allocation; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Trinitrobenzenesulfonic Acid | 2006 |